Hermanns, Thomas

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 22.

Pavlovic, Blaz; Bräutigam, Konstantin; Dartiguenave, Florence; Martel, Paul; Rakauskas, Arnas; Cesson, Valérie; Veit, Markus; Oechslin, Pascal; Gu, Alexander; Hermanns, Thomas; Saba, Karim; Poyet, Cédric; Hötker, Andreas M; Rupp, Niels J; Valerio, Massimo; Derré, Laurent; Eberli, Daniel; Banzola, Irina (2024). Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy. Scientific Reports, 14(18148) Nature Publishing Group 10.1038/s41598-024-68026-1

Speicher, Philip; Fankhauser, Christian D; Lorch, Anja; Ardizzone, Davide; Helnwein, Simon; Hoch, Dennis; Hermanns, Thomas; Beyer, Jörg; Akhoundova, Dilara (2023). Excellent survival in relapsed stage I testicular cancer. BMC cancer, 23(1), p. 870. BioMed Central 10.1186/s12885-023-11388-y

Notarfrancesco, Marco; Fankhauser, Christian D; Lorch, Anja; Ardizzone, Davide; Helnwein, Simon; Hoch, Dennis; Hermanns, Thomas; Thalmann, George; Beyer, Jörg (2023). Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review. Swiss medical weekly, 153, p. 40053. SMW supporting association 10.57187/smw.2023.40053

Fischer, Stefanie; Rothermundt, Christian; Stalder, Odile; Terbuch, Angelika; Hermanns, Thomas; Zihler, Deborah; Müller, Beat; Fankhauser, Christian D; Hirschi-Blickenstorfer, Anita; Seifert, Bettina; Kluth, Luis Alex; Ufe, Mark-Peter; Mingrone, Walter; Templeton, Arnoud J; Fischer, Natalie; Rothschild, Sacha; Woelky, Regina; Gillessen, Silke; Cathomas, Richard (2023). The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study. European urology open science, 50, pp. 57-60. Elsevier 10.1016/j.euros.2023.01.013

Hoch, Dennis; Helnwein, Simon; Adrizzone, Davide; Lorch, Anja; Fankhauser, Christian; Hermanns, Thomas; Thalmann, George; Beyer, Jörg (2023). No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas. Oncology research and treatment, 46(10), pp. 435-439. Karger 10.1159/000533505

Christiansen, Ailsa J; Lobo, João; Fankhauser, Christian D; Rothermundt, Christian; Cathomas, Richard; Batavia, Aashil A; Grogg, Josias B; Templeton, Arnoud J; Hirschi-Blickenstorfer, Anita; Lorch, Anja; Gillessen, Silke; Moch, Holger; Beyer, Jörg; Hermanns, Thomas (2022). Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence. Frontiers in oncology, 12(1056823), p. 1056823. Frontiers Research Foundation 10.3389/fonc.2022.1056823

Grogg, Josias Bastian; Dursun, Zeynep Hafza; Beyer, Joerg; Eberli, Daniel; Poyet, Cedric; Hermanns, Thomas; Fankhauser, Christian Daniel (2022). Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases. World journal of urology, 40(9), pp. 2293-2303. Springer 10.1007/s00345-022-04048-6

Pratsinis, Manolis; Fankhauser, Christian; Pratsinis, Katerina; Beyer, Jörg; Bührer, Emanuel; Cathomas, Richard; Fischer, Natalie; Hermanns, Thomas; Hirschi-Blickenstorfer, Anita; Kamradt, Jörn; Alex Kluth, Luis; Zihler, Deborah; Mingrone, Walter; Müller, Beat; Nestler, Tim; Rothschild, Sacha I; Seifert, Bettina; Templeton, Arnoud J; Terbuch, Angelika; Ufen, Mark-Peter; ... (2022). Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses. European urology open science, 40, pp. 16-18. Elsevier 10.1016/j.euros.2022.03.013

Fankhauser, Christian D; Christiansen, Ailsa J; Rothermundt, Christian; Cathomas, Richard; Wettstein, Marian S; Grossmann, Nico C; Grogg, Josias B; Templeton, Arnoud J; Hirschi-Blickenstorfer, Anita; Lorch, Anja; Gillessen, Silke; Moch, Holger; Beyer, Joerg; Hermanns, Thomas (2022). Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. British journal of cancer, 126(8), pp. 1140-1144. Springer Nature 10.1038/s41416-021-01643-z

Fankhauser, Christian Daniel; Roth, Lisa; Kranzbühler, Benedikt; Eberli, Daniel; Bode, Peter; Moch, Holger; Oliveira, Pedro; Ramani, Vijay; Beyer, Joerg; Hermanns, Thomas (2021). The Role of Frozen Section Examination During Inguinal Exploration in Men with Inconclusive Testicular Tumors: A Systematic Review and Meta-analysis. European urology focus, 7(6), pp. 1400-1402. Elsevier 10.1016/j.euf.2020.06.019

Grogg, Josias Bastian; Fronzaroli, Jordi Nicola; Oliveira, Pedro; Bode, Peter-Karl; Lorch, Anja; Issa, Allaudin; Beyer, Joerg; Eberli, Daniel; Sangar, Vijay; Hermanns, Thomas; Clarke, Noel William; Fankhauser, Christian Daniel (2021). Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data. Journal of cancer research and clinical oncology, 147(9), pp. 2671-2679. Springer 10.1007/s00432-021-03533-6

Beyer, Jörg; Berthold, Dominik; Bode, Peter-Karl; Cathomas, Richard; Fankhauser, Christian D; Fischer, Stefanie; Gillessen, Silke; Gross, Tobias; Hermanns, Thomas; Honecker, Friedemann; Lorch, Anja; Omlin, Aurelius; Papachristofilou, Alexandros; Roth, Beat; Rothermundt, Christian; Seiler, Roland; Spahn, Martin; Stenner, Frank; Bührer, Emanuel (2021). Swiss germ-cell cancer consensus recommendations. Swiss medical weekly, 151(33-34) EMH Schweizerischer Ärzteverlag 10.4414/SMW.2021.w30023

Gallo, Alessandra; Fankhauser, Christian; Hermanns, Thomas; Beyer, Jörg; Christiansen, Ailsa; Moch, Holger; Bode, Peter Karl (2020). HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors. Modern pathology, 33(11), pp. 2354-2360. Springer Nature 10.1038/s41379-020-0597-x

Grogg, Josias Bastian; Schneider, Kym; Bode, Peter-Karl; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Beyer, Joerg; Lorch, Anja; Hermanns, Thomas; Fankhauser, Christian Daniel (2020). Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data. Journal of cancer research and clinical oncology, 146(11), pp. 2829-2841. Springer 10.1007/s00432-020-03326-3

Grogg, Josias; Schneider, Kym; Bode, Peter Karl; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Lorch, Anja; Beyer, Joerg; Hermanns, Thomas; Fankhauser, Christian Daniel (2020). Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 Patients. The oncologist, 25(7), pp. 585-590. AlphaMed Press 10.1634/theoncologist.2019-0692

Fankhauser, Christian Daniel; Gerke, Travis A.; Roth, Lisa; Sander, Sophia; Grossmann, Nico Christian; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Beyer, Jörg; Hermanns, Thomas (2019). Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment. Journal of cancer research and clinical oncology, 145(3), pp. 781-785. Springer 10.1007/s00432-019-02844-z

Fankhauser, Christian Daniel; Sander, Sophia; Roth, Lisa; Gross, Oliver; Eberli, Daniel; Sulser, Tullio; Seifert, Burkhardt; Beyer, Jörg; Hermanns, Thomas (2018). Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. British journal of cancer, 118(6), pp. 825-830. Nature Publishing Group 10.1038/bjc.2017.467

Mortezavi, Ashkan; Salemi, Souzan; Rupp, Niels J; Rüschoff, Jan Hendrik; Hermanns, Thomas; Poyet, Cedric; Randazzo, Marco; Simon, Hans-Uwe; Moch, Holger; Sulser, Tullio; Wild, Peter; Eberli, Daniel (2017). Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death. OncoTarget, 8(19), pp. 31765-31774. Impact Journals LLC 10.18632/oncotarget.15986

Montani, Matteo; Hermanns, Thomas; Müntener, Michael; Wild, Peter; Sulser, Tullio; Kristiansen, Glen (2013). Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression. Virchows Archiv, 462(4), pp. 437-443. Springer 10.1007/s00428-013-1390-8

Gerhardt, Josefine; Montani, Matteo; Wild, Peter; Beer, Marc; Huber, Fabian; Hermanns, Thomas; Müntener, Michael; Kristiansen, Glen (2012). FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer. American journal of pathology, 180(2), pp. 848-61. New York, N.Y.: Elsevier 10.1016/j.ajpath.2011.10.021

Beer, Marc; Montani, Matteo; Gerhardt, Josefine; Wild, Peter J; Hany, Thomas F; Hermanns, Thomas; Müntener, Michael; Kristiansen, Glen (2012). Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates. Prostate, 72(3), pp. 318-25. Hoboken, N.J.: Wiley-Blackwell 10.1002/pros.21434

Mortezavi, Ashkan; Hermanns, Thomas; Seifert, Hans-Helge; Baumgartner, Martin K; Provenzano, Maurizio; Sulser, Tullio; Burger, Maximilian; Montani, Matteo; Ikenberg, Kristian; Hofstädter, Ferdinand; Hartmann, Arndt; Jaggi, Rolf; Moch, Holger; Kristiansen, Glen; Wild, Peter J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical cancer research, 17(5), pp. 1111-21. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-10-0081

This list was generated on Sat Nov 23 21:17:14 2024 CET.
Provide Feedback